Lupin’s arm receives GMP certification from Therapeutic Goods Administration

18 Jul 2025 Evaluate

Lupin’s wholly owned subsidiary -- Lupin Manufacturing Solutions (LMS) has received the good manufacturing practice (GMP) certification from the Therapeutic Goods Administration (TGA), Australia’s medicines and medical devices regulator for its API manufacturing facility in Dabhasa, Gujarat. LMS offers pharmaceutical CDMO services and is engaged in the manufacturing and supply of APIs.

Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.

Lupin Share Price

2093.00 1.05 (0.05%)
05-Dec-2025 15:26 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1805.00
Dr. Reddys Lab 1275.25
Cipla 1520.40
Zydus Lifesciences 931.70
Lupin 2093.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×